C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
🔥
👍
💩
Founded
2019
Employees
Funding
Team members (0 of 0)
No team members found
Team member data will appear here when available
Investment History
Premium Feature
Upgrade to see detailed investment rounds, funding amounts, and investor information
